Beijing SL Pharmaceutical Stock Forecast for 2023 - 2025 - 2030
Updated on 04/28/2024
Beijing SL Pharmaceutical Stock Forecast and Price Target
If Beijing SL Pharmaceutical's stock price reached the average yearlong target of ¥12.00 given by well-known analysts in recent months, there would be a potential upside of approximately 43.2% from its last closing price in April, 2024. This potential increase is based on a high estimate of ¥12.00 and a low estimate of ¥12.00. If you're looking for information on Beijing SL Pharmaceutical stock, consider checking out the forecasts for comparable firms such as SHSE:600201.
43.20% Upside
Beijing SL Pharmaceutical Fair Value Forecast for 2023 - 2025 - 2030
In the last year, Beijing SL Pharmaceutical's Price has decreased by 100.00%, going from ¥7.86 to ¥0.00. In the next year, analysts believe that Fair Value will reach ¥10.25 – an increase of 100.00%. For the next seven years, the forecast is for Fair Value to grow by 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| 300122 Stock Forecast | Chongqing Zhifei Biological Pr... | Buy |
16
|
¥34.83 | Buy/Sell | ¥72.72 | 86.62% |
| 1801 Stock Forecast | Innovent Biologics | Buy |
6
|
HK$39.15 | Buy/Sell | HK$50.72 | 29.76% |
| 600161 Stock Forecast | Beijing Tiantan Biological Pro... | Outperform |
18
|
¥28.55 | Buy/Sell | ¥31.28 | 11.59% |
| 002252 Stock Forecast | Shanghai RAAS Blood Products | Buy |
18
|
¥7.19 | Buy/Sell | ¥9.08 | -2.64% |
| 000661 Stock Forecast | Changchun High-Tech Industries... | Buy |
18
|
¥111.42 | Buy/Sell | ¥211.29 | 75.33% |
Beijing SL Pharmaceutical Revenue Forecast for 2023 - 2025 - 2030
In the last three years, Beijing SL Pharmaceutical's Revenue has decreased by 8.48%, going from ¥1.11B to ¥1.02B. In the next year, analysts believe that Revenue will reach ¥1.05B – an increase of 3.47%. For the next seven years, the forecast is for Revenue to grow by 6.17%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| 002007 Stock Forecast | Hualan Biological Engineering | Outperform |
18
|
¥18.54 | Buy/Sell | ¥25.89 | 40.78% |
| NasdaqGS:CBPO Stock Forecast | China Biologic Products Holdin... | - |
16
|
$118.41 | Buy/Sell | $103.00 | -100.00% |
| 9926 Stock Forecast | Akeso | Buy |
4
|
HK$48.70 | Buy/Sell | HK$49.90 | 13.20% |
.jpg)
Beijing SL Pharmaceutical Dividend per Share Forecast for 2023 - 2025 - 2030
In the last two years, Beijing SL Pharmaceutical's Dividend per Share has decreased from ¥0.10 to ¥0.10 – a 0.00% drop. For the next year, analysts predict that Dividend per Share will reach ¥0.15 – an increase of 50.00%. Over the next seven years, experts believe that Beijing SL Pharmaceutical's Dividend per Share will grow at a rate of 42.27%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| 1877 Stock Forecast | Shanghai Junshi Biosciences | Outperform |
7
|
HK$10.74 | Buy/Sell | HK$31.29 | 77.09% |
| 688278 Stock Forecast | Xiamen Amoytop Biotech | Buy |
15
|
¥61.34 | Buy/Sell | ¥83.00 | 45.42% |
| 300142 Stock Forecast | Walvax Biotechnology | Hold |
15
|
¥14.33 | Buy/Sell | ¥22.00 | 39.57% |
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| 000403 Stock Forecast | Pacific Shuanglin Bio-pharmacy... | Buy |
16
|
¥29.87 | Buy/Sell | ¥25.94 | 0.44% |
| 300601 Stock Forecast | Shenzhen Kangtai Biological Pr... | Buy |
16
|
¥20.75 | Buy/Sell | ¥36.61 | 68.67% |
| 300676 Stock Forecast | BGI Genomics | - |
17
|
¥39.74 | Buy/Sell | ¥0.00 | -100.00% |
Beijing SL Pharmaceutical EBITDA Forecast for 2023 - 2025 - 2030
In the last three years, Beijing SL Pharmaceutical's EBITDA has seen an increase, rising from ¥239.38M to ¥395.53M. This represents a growth of 65.23%. The next year, 0 experts forecast that Beijing SL Pharmaceutical's EBITDA will decrease by 12.31%, reaching ¥346.83M. In 2030, professionals predict that Beijing SL Pharmaceutical's EBITDA will decrease by 14.22%, reaching ¥339.28M.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| 300009 Stock Forecast | Anhui Anke Biotechnology (Grou... | Buy |
18
|
¥9.93 | Buy/Sell | ¥19.54 | 96.78% |
| 300294 Stock Forecast | China Resources Boya Bio-pharm... | Outperform |
16
|
¥31.28 | Buy/Sell | ¥35.07 | 9.78% |
| 002030 Stock Forecast | Daan Gene | - |
17
|
¥8.37 | Buy/Sell | ¥0.00 | -100.00% |
Beijing SL Pharmaceutical EBIT Forecast for 2023 - 2025 - 2030
Beijing SL Pharmaceutical's EBIT has seen growth In the last three years, going from ¥149.91M to ¥250.14M – a gain of 66.86% According to the 0 analysts polled, in the next year, Beijing SL Pharmaceutical's EBIT will fall by 8.06%, reaching ¥229.98M. By 2030, professionals believe that Beijing SL Pharmaceutical's EBIT will have decreased by 10.29%, falling to ¥224.40M.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| 1530 Stock Forecast | 3SBio | Outperform |
14
|
HK$6.08 | Buy/Sell | HK$7.92 | 13.98% |
| 688266 Stock Forecast | Suzhou Zelgen Biopharmaceutica... | Buy |
8
|
¥53.40 | Buy/Sell | ¥58.00 | 19.85% |
| 300026 Stock Forecast | Tianjin Chase Sun Pharmaceutic... | Buy |
14
|
¥3.69 | Buy/Sell | ¥7.66 | 8.40% |
Beijing SL Pharmaceutical EPS Price Prediction Forecast for 2023 - 2025 - 2030
In the last year, Beijing SL Pharmaceutical's EPS has decreased by 100.00%, going from ¥0.23 to ¥0.00. In the next year, analysts believe that EPS will reach ¥0.30 – an increase of 100.00%. For the next seven years, the forecast is for EPS to grow by 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| 300406 Stock Forecast | Beijing Strong Biotechnologies... | Buy |
18
|
¥18.70 | Buy/Sell | ¥0.00 | -100.00% |
| 000990 Stock Forecast | Chengzhi | Buy |
15
|
¥7.73 | Buy/Sell | ¥0.00 | -100.00% |
| ZLAB Stock Forecast | Zai Lab | Buy |
6
|
$15.91 | Buy/Sell | $66.67 | 280.26% |
Site Navigation
.jpg)